Literature DB >> 9573286

Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages.

M L Linn1, L Mateo, J Gardner, A Suhrbier.   

Abstract

Persistent alphavirus infections in synovial and neural tissues are believed to be associated with chronic arthritis and encephalitis, respectively, and represent likely targets for CD8+ alphabeta cytotoxic T lymphocytes (CTL). Here we show that the capsid protein is a dominant target for alphavirus-specific CTL in BALB/c mice and that capsid-specific CTL from these mice recognize an H-2Kd restricted epitope, QYSGGRFTI. This epitope lies in the highly conserved region of the capsid protein, and QYSGGRFTI-specific CTL were cross reactive across a range of Old World alphaviruses. In vivo the acute primary viraemia of these highly cytopathic viruses was unaffected by QYSGGRFTI-specific CTL. However, in vitro these CTL were able to completely clear virus from macrophages persistently and productively infected with the arthrogenic alphavirus Ross River virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573286      PMCID: PMC110085          DOI: 10.1128/JVI.72.6.5146-5153.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Reinfection-induced increase of rubella persistently infected cells in a macrophage-like cell line.

Authors:  R E Sarmiento; R Tirado; B Gómez
Journal:  Virus Res       Date:  1997-07       Impact factor: 3.303

Review 2.  To kill or to cure: options in host defense against viral infection.

Authors:  L G Guidotti; F V Chisari
Journal:  Curr Opin Immunol       Date:  1996-08       Impact factor: 7.486

3.  Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus.

Authors:  S G Faragher; A D Meek; C M Rice; L Dalgarno
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

Review 4.  Rheumatic manifestations of tropical diseases.

Authors:  A O Adebajo
Journal:  Curr Opin Rheumatol       Date:  1996-01       Impact factor: 5.006

5.  Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years.

Authors:  E B Rwaguma; J J Lutwama; S D Sempala; N Kiwanuka; J Kamugisha; S Okware; G Bagambisa; R Lanciotti; J T Roehrig; D J Gubler
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

6.  Parvovirus B19 clearance from peripheral blood after acute infection.

Authors:  M Musiani; M Zerbini; G Gentilomi; M Plazzi; G Gallinella; S Venturoli
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

7.  Development of specific antibody patterns and clinical symptoms following Ockelbo virus infection.

Authors:  S Vene; C Franzén; B Niklasson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Development of a candidate vaccine against Ross River virus infection.

Authors:  S Yu; J G Aaskov
Journal:  Vaccine       Date:  1994-09       Impact factor: 3.641

9.  Expression of Semliki Forest virus nsP1-specific methyltransferase in insect cells and in Escherichia coli.

Authors:  P Laakkonen; M Hyvönen; J Peränen; L Kääriäinen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-alpha or taxol.

Authors:  M J Sweet; D A Hume
Journal:  J Inflamm       Date:  1995
View more
  19 in total

1.  Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Authors:  Haiyan Chu; Subash C Das; Jeremy F Fuchs; M Suresh; Scott C Weaver; Dan T Stinchcomb; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2013-05-29       Impact factor: 3.641

2.  Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.

Authors:  T Woodberry; J Gardner; L Mateo; D Eisen; J Medveczky; I A Ramshaw; S A Thomson; R A Ffrench; S L Elliott; H Firat; F A Lemonnier; A Suhrbier
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 3.  Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology.

Authors:  Teck-Hui Teo; Fok-Moon Lum; Wendy W L Lee; Lisa F P Ng
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  Biology and pathogenesis of chikungunya virus.

Authors:  Olivier Schwartz; Matthew L Albert
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

Review 5.  Ross River virus transmission, infection, and disease: a cross-disciplinary review.

Authors:  D Harley; A Sleigh; S Ritchie
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.

Authors:  Charalambos D Partidos; James Weger; Joseph Brewoo; Robert Seymour; Erin M Borland; Jeremy P Ledermann; Ann M Powers; Scott C Weaver; Dan T Stinchcomb; Jorge E Osorio
Journal:  Vaccine       Date:  2011-02-05       Impact factor: 3.641

7.  Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

Authors:  Ludmila Krymskaya; Madeva C Sharma; Joy Martinez; Wahajul Haq; Eric C Huang; Ajit P Limaye; Don J Diamond; Simon F Lacey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

Review 9.  Replication cycle of chikungunya: a re-emerging arbovirus.

Authors:  Maxime Solignat; Bernard Gay; Stephen Higgs; Laurence Briant; Christian Devaux
Journal:  Virology       Date:  2009-09-04       Impact factor: 3.616

10.  Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice.

Authors:  Amanda Piper; Mariana Ribeiro; Katherine M Smith; Caitlin M Briggs; Emerson Huitt; Kavita Nanda; Carla J Spears; Michelle Quiles; John Cullen; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.